Lyrica Cr Tablet, Film Coated, Extended Release
Product Images NDC 58151-246

6 FDA label images from Viatris Specialty Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lyrica Cr (NDC 58151-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cockcroft And Gault Equation (Image 01)

Cockcroft And Gault Equation (Image 01)
A formula for estimating creatinine clearance (CLCr) is shown, involving age, weight, serum creatinine, and a factor for female patients. This text panel appears to be a pharmacokinetic calculation related to Lyrica CR (pregabalin) extended-release tablets.*
FDA Label Image

Chemical Structure Of Pregabalin (Image 02)

Chemical Structure Of Pregabalin (Image 02)
Chemical structure of pregabalin, showing the molecular arrangement including amine and carboxyl functional groups with its carbon backbone.*
FDA Label Image

Figure 1. Percent Of Patients Achieving Various Levels Of Improvement In Pain Intensity (n=413) (Image 03)

Figure 1. Percent Of Patients Achieving Various Levels Of Improvement In Pain Intensity (n=413) (Image 03)
A line graph comparing the percent improvement in pain from baseline between Pregabalin and placebo groups. The x-axis represents percent improvement thresholds from greater than 0 to 100%, and the y-axis shows the percent of patients improved, ranging from 0 to 100%. Two curves depict patient improvement percentages for Pregabalin (solid line) and placebo (dashed line).*
FDA Label Image

Lyrica Cr Er Tablets 82.5 mg Bottle Label (Image 04)

Lyrica Cr Er Tablets 82.5 mg Bottle Label (Image 04)
Lyrica CR 82.5 mg extended release tablets, film coated, oral dosage form, by Viatris Specialty LLC. The label indicates storage instructions, dosage strength, prescription only status, and packaging of 30 tablets. It includes barcode and manufacturing details with distribution by Viatris Specialty LLC, Morgantown, WV, made in Germany.*
FDA Label Image

Lyrica Cr Er Tablets 165 mg Bottle Label (Image 05)

Lyrica Cr Er Tablets 165 mg Bottle Label (Image 05)
Lyrica CR 165 mg extended release tablets label showing the brand and generic name pregabalin. The label indicates 30 film-coated tablets for oral use, distributed by Viatris Specialty LLC. It includes storage instructions, dosage form, a barcode, and NDC 58151-246-93. The label also notes the tablets are prescription only and made in Germany.*
FDA Label Image

Lyrica Cr Er Tablets 330 mg Bottle Label (Image 06)

Lyrica Cr Er Tablets 330 mg Bottle Label (Image 06)
Lyrica CR 330 mg film-coated extended release tablets label shows the proprietary and generic name pregabalin. This prescription oral tablet comes in a 30-count bottle and is distributed by Viatris Specialty LLC. Storage instructions specify 20°C to 25°C with permitted excursions, and the label highlights the need to always dispense with the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.